Cleared Traditional

K243014 - EyeQ nanoECP

K243014 is an FDA 510(k) clearance for EyeQ nanoECP, manufactured by Eyeq, Inc.. The device is a Class 2 Ophthalmic device with product code HQF cleared through the Traditional 510(k) pathway after a 264-day FDA review.

K243014 · Eyeq, Inc. · Ophthalmic device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 2025
Decision
264d
Days
Class 2
Risk

K243014 is an FDA 510(k) clearance for the EyeQ nanoECP. Classified as Laser, Ophthalmic (product code HQF), Class II - Special Controls.

Submitted by Eyeq, Inc. (Reno, US). The FDA issued a Cleared decision on June 18, 2025 after a review of 264 days - an extended review cycle.

This device falls under the Ophthalmic FDA review panel, regulated under 21 CFR 886.4390 - the FDA ophthalmic device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Ophthalmic review framework, consistent with the majority of Class II 510(k) submissions.

View all Eyeq, Inc. devices

FDA 510(k) Submission Details - K243014

510(k) Number K243014 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 27, 2024
Decision Date June 18, 2025
Days to Decision 264 days
Submission Type Traditional
Review Panel Ophthalmic (OP)
Summary Statement
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
154d slower than avg
Panel avg: 110d · This submission: 264d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

HQF Device Classification - Class 2, Special Controls

Product Code HQF Laser, Ophthalmic
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 886.4390
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Ophthalmic devices follow this clearance model.

Regulatory Peers - HQF Laser, Ophthalmic

All 85
Devices cleared under the same product code (HQF) and FDA review panel - the closest regulatory comparables to K243014.
Voyager DSLT (430840610)
K252979 · Belkin Vision, Ltd. · Apr 2026
INTEGRE LIO
K251507 · Quantel Medical · Feb 2026
Navilas Laser System 577sl (156691)
K251772 · Od-Os GmbH · Oct 2025
Leos Laser and Endoscopy System
K240615 · Beaver-Visitec International, Inc. · Apr 2025
LYNX Photocoagulator
K242397 · Norlase Aps · Oct 2024
VISULAS combi
K233911 · Carl Zeiss Meditec, AG · Sep 2024